Literature DB >> 7796894

Apoptosis induced by IL-2 withdrawal is associated with an intracellular acidification.

A Rebollo1, J Gómez, A Martínez de Aragón, P Lastres, A Silva, D Pérez-Sala.   

Abstract

It is known that phorbol esters can protect IL-2-dependent lymphocytes against apoptosis induced by IL-2 withdrawal. However, the mechanism of this effect remains unclear. In this article we show that apoptosis induced by IL-2 withdrawal in the CTLL-2 cell line correlates with a decrease in intracellular pH (pHi). Supplementing the incubation medium with phorbol esters during IL-2 deprivation protects CTLL-2 cells against both apoptosis and intracellular acidification. Interestingly, IL-4 also supports short-term cell survival and maintenance of normal pHi. The protein kinase inhibitor staurosporine prevents the protective effects of IL-2, PMA, and IL-4 on apoptosis and intracellular acidification. In contrast, inhibition of the Na+/H+ antiporter by 5-N-ethyl-N-isopropyl amiloride reverts the protective effects of PMA and IL-4, but only weakly affects IL-2-mediated suppression of apoptosis. Taken together, these results indicate that intracellular acidification may be an important event during apoptosis induced by IL-2 deprivation in the CTLL-2 cell line. Moreover, they suggest a key role for protein kinase C activation both in the maintenance of pHi and in the suppression of apoptosis, through mechanisms which rely on the activation of the Na+/H+ antiporter to a different extent, depending on the rescuing factor employed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796894     DOI: 10.1006/excr.1995.1195

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival.

Authors:  S Gollapud; S Gupta
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

2.  Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis.

Authors:  R A Gottlieb; D L Gruol; J Y Zhu; R L Engler
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 3.  Role of intracellular pH in proliferation, transformation, and apoptosis.

Authors:  L D Shrode; H Tapper; S Grinstein
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

4.  Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis.

Authors:  Y T Hsu; K G Wolter; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Regulation of proliferation-survival decisions during tumor cell hypoxia.

Authors:  C Schmaltz; P H Hardenbergh; A Wells; D E Fisher
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas.

Authors:  R Marches; E S Vitetta; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

7.  A study of PKM2, PFK-1, and ANT1 expressions in cervical biopsy tissues in China.

Authors:  Yang Yuan; Peng Guo-Qing; Tian Yan; Ying Hong-Lin; Hu Gong-Hua; Zhong Cai-Gao
Journal:  Med Oncol       Date:  2012-01-08       Impact factor: 3.064

8.  Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes.

Authors:  X Long; M T Crow; S J Sollott; L O'Neill; D S Menees; M de Lourdes Hipolito; M O Boluyt; T Asai; E G Lakatta
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

9.  An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).

Authors:  Salvador Harguindey; Gorka Orive; Ramón Cacabelos; Enrique Meléndez Hevia; Ramón Díaz de Otazu; Jose Luis Arranz; Eduardo Anitua
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.